Flora Peyvandi (F Peyvandi)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 177

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Blood advances

Journal of thrombosis and haemostasis : JTH

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Shermarke Hassan, Guido A Baselli, Luca Mollica, Riccardo L Rossi, Himani Chand, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Mehran Karimi, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort. Blood advances 8 (11) (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michiel Coppens, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Greta Mulders, Flora Peyvandi
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD). Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Alessandro Casini, David J Kuter, Catherine P M Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Raffaella Rossio, Mauro Tettamanti, Alessia Antonella Galbussera, Roberta Gualtierotti, Andrea Giachi, Adriana Torri, Nicola Montano, Anna Ludovica Fracanzani, Alessandra Bandera, Alessandro Nobili, Flora Peyvandi, null null
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19. Internal and emergency medicine (2024)
Shermarke Hassan, Guido A Baselli, Luca Mollica, Riccardo L Rossi, Himani Chand, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Mehran Karimi, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort. Blood advances 8 (11) (2024)
Samin Mohsenian, Roberta Palla, Marzia Menegatti, Andrea Cairo, Anna Lecchi, Alessandro Casini, Marguerite Neerman-Arbez, Rosanna Asselta, Sara Scardo, Siboni Simona Maria, Jan Blatny, Ondrej Zapletal, Jean-Francois Schved, Muriel Giansily-Blaizot, Susan Halimeh, Mohamad Ayman Daoud, Helen Platokouki, Helen Pergantou, Roger E G Schutgens, Monique Van Haaften-Spoor, Paul Brons, Britta Laros-van Gorkom, Elise Van Pinxten, Munira Borhany, Naveena Fatima, Danijela Mikovic, Marko Saracevic, Gül Nihal Özdemir, Yılmaz Ay, Michael P Makris, Caryl Lockley, Andrew D Mumford, Andrew Harvey, Steve Austin, Amy Shapiro, Adrianna Williamson, Catherine McGuinn, Ilene Goldberg, Philippe De Moerloose, Flora Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database. Blood advances 8 (6) (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Shermarke Hassan, Guido A Baselli, Luca Mollica, Riccardo L Rossi, Himani Chand, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Mehran Karimi, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort. Blood advances 8 (11) (2024)
Omid Seidizadeh, Luca Mollica, Serena Zambarbieri, Luciano Baronciani, Andrea Cairo, Paola Colpani, Giovanna Cozzi, Maria Teresa Pagliari, Alessandro Ciavarella, Siboni Simona Maria, Flora Peyvandi
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A. Blood advances 8 (7) (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Alessandro Casini, David J Kuter, Catherine Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Pasquale Agosti, Simona Maria Siboni, Alessandro Ciavarella, Sara Arcudi, Federico Boggio, Roberta Gualtierotti, Flora Peyvandi
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Samin Mohsenian, Roberta Palla, Marzia Menegatti, Andrea Cairo, Anna Lecchi, Alessandro Casini, Marguerite Neerman-Arbez, Rosanna Asselta, Sara Scardo, Siboni Simona Maria, Jan Blatny, Ondrej Zapletal, Jean-Francois Schved, Muriel Giansily-Blaizot, Susan Halimeh, Mohamad Ayman Daoud, Helen Platokouki, Helen Pergantou, Roger E G Schutgens, Monique Van Haaften-Spoor, Paul Brons, Britta Laros-van Gorkom, Elise Van Pinxten, Munira Borhany, Naveena Fatima, Danijela Mikovic, Marko Saracevic, Gül Nihal Özdemir, Yılmaz Ay, Michael P Makris, Caryl Lockley, Andrew D Mumford, Andrew Harvey, Steve Austin, Amy Shapiro, Adrianna Williamson, Catherine McGuinn, Ilene Goldberg, Philippe De Moerloose, Flora Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database. Blood advances 8 (6) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Omid Seidizadeh, Jeroen C J Eikenboom, Cecile V Denis, Veronica H Flood, Paula James, Peter J Lenting, Luciano Baronciani, James S O'Donnell, David Lillicrap, Flora Peyvandi
von Willebrand disease. Nature reviews. Disease primers 10 (1) (2024)
Omid Seidizadeh, Andrea Cairo, Illaria Mancini, James N George, Flora Peyvandi
Global Prevalence of Hereditary Thrombotic Thrombocytopenic Purpura Determined by Genetic Analysis. Blood advances (2024)
Massimo Morfini, Flora Peyvandi, Maria Elisa Mancuso, Emanuela Marchesini, Annarita Tagliaferri, Roberta Gualtierotti, Giancarlo Castaman, Berardino Pollio, Cristina Santoro, Luisa Banov, Mariasanta Napolitano, Paola Stefania Preti, Rita Carlotta Santoro, Antonio Coppola, Silvia Linari, Elena Santagostino, Francesco Bernardi
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. Journal of clinical medicine 13 (17) (2024)
Paola Giordano, Berardino Pollio, Gianluca Sottilotta, Chiara Biasoli, Filomena Daniele, Raimondo De Cristofaro, Flora Peyvandi, Maria Rosaria Villa, Giancarlo Castaman, null null
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study. European journal of haematology 112 (5) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Paola Giordano, Berardino Pollio, Gianluca Sottilotta, Chiara Biasoli, Filomena Daniele, Raimondo De Cristofaro, Flora Peyvandi, Maria Rosaria Villa, Giancarlo Castaman, null null
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study. European journal of haematology (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Paola Giordano, Berardino Pollio, Gianluca Sottilotta, Chiara Biasoli, Filomena Daniele, Raimondo De Cristofaro, Flora Peyvandi, Maria Rosaria Villa, Giancarlo Castaman, null null
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study. European journal of haematology (2024)
Jeremy W Jacobs, Caroline G Stanek, Garrett S Booth, Argiris Symeonidis, Andrew W Shih, Elizabeth S Allen, Eugenia Gkaliagkousi, Brenda J Grossman, Katerina Pavenski, Amy Moorehead, Flora Peyvandi, Pasquale Agosti, Illaria Mancini, Laura D Stephens, Jay S Raval, Maria-Eva Mingot-Castellano, Elizabeth P Crowe, Laetitia Daou, Menaka Pai, Donald M Arnold, Marisa B Marques, Ryan Henrie, Tyler W Smith, Gayatri Sreenivasan, Rance C Siniard, Lisa R Wallace, Chisa Yamada, Miriam Andrea Duque, Yanyun Wu, Thomas J Harrington, Diana M Byrnes, Aikaterini Bitsani, Amanda K Davis, Danielle H Robinson, Quentin Eichbaum, Cristina A Figueroa Villalba, Justin E Juskewitch, Georgia Kaiafa, Eleni Kapsali, Ellen Klapper, Ingrid Perez-Alvarez, Monica S Klein, Nikolaos Kotsiou, Chrysavgi Lalayanni, Evdokia Mandala, Fatima Aldarweesh, Rahaf Alkhateb, Lisandro Fortuny, Zois Mellios, Apostolia Papalexandri, Meredith G Parsons, Annette J Schlueter, Christopher A Tormey, Cameron Wellard, Erica Michelle Wood, Shiyang Jia, Allison P Wheeler, Amy A Powers, Christopher B Webb, Sean G Yates, Raïda Bouzid, Paul Coppo, Evan M Bloch, Brian David Adkins
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes. American journal of hematology (2024)
Vincenzo la Mura, Vincenzo Cardinale, Raimondo De Cristofaro, Adriano De Santis, Giovanni Di Minno, Luca Fabris, Fabio Marra, Filomena Morisco, Flora Peyvandi, Maurizio Pompili, Cristina Santoro, Ezio Zanon, Giancarlo Castaman
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice. Blood advances (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances (2024)
Paola Giordano, Berardino Pollio, Gianluca Sottilotta, Chiara Biasoli, Filomena Daniele, Raimondo De Cristofaro, Flora Peyvandi, Maria Rosaria Villa, Giancarlo Castaman, null null
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study. European journal of haematology 112 (5) (2024)
Lynn Malec, Flora Peyvandi, Anthony K C Chan, Christoph Königs, Bulent Zulfikar, Huixing Yuan, Mindy Simpson, Maria Teresa Álvarez Román, Manuel Carcao, Janice M Staber, Amy L Dunn, Sheng-Chieh Chou, Roseline d'Oiron, Manuela Albisetti, Marek Demissie, Elena Santagostino, Abhimanyu Yarramaneni, Nancy Wong, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat, null null
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A. The New England journal of medicine 391 (3) (2024)
Roberta Gualtierotti, Andrea Giachi, Addolorata Truma, Sara Arcudi, Alessandro Ciavarella, Paolo Bucciarelli, Dario Consonni, Elena Boccalandro, Valentina Begnozzi, Luigi Piero Solimeno, Simona Maria Siboni, Flora Peyvandi
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Lynn Malec, Flora Peyvandi, Anthony K C Chan, Christoph Königs, Bulent Zulfikar, Huixing Yuan, Mindy Simpson, Maria Teresa Álvarez Román, Manuel Carcao, Janice M Staber, Amy L Dunn, Sheng-Chieh Chou, Roseline d'Oiron, Manuela Albisetti, Marek Demissie, Elena Santagostino, Abhimanyu Yarramaneni, Nancy Wong, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat, null null
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A. The New England journal of medicine 391 (3) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michael P Makris, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Mike Makris, Greta Mulders, Flora Peyvandi
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challenges. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michael P Makris, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Mike Makris, Greta Mulders, Flora Peyvandi
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challenges. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Roberta Gualtierotti, Andrea Giachi, Addolorata Truma, Sara Arcudi, Alessandro Ciavarella, Paolo Bucciarelli, Dario Consonni, Elena Boccalandro, Valentina Begnozzi, Luigi Piero Solimeno, Simona Maria Siboni, Flora Peyvandi
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Pasquale Agosti, Simona Maria Siboni, Alessandro Ciavarella, Sara Arcudi, Federico Boggio, Roberta Gualtierotti, Flora Peyvandi
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Pasquale Agosti, Simona Maria Siboni, Alessandro Ciavarella, Sara Arcudi, Federico Boggio, Roberta Gualtierotti, Flora Peyvandi
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC. Impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Omid Seidizadeh, Luca Mollica, Serena Zambarbieri, Luciano Baronciani, Andrea Cairo, Paola Colpani, Giovanna Cozzi, Maria Teresa Pagliari, Alessandro Ciavarella, Siboni Simona Maria, Flora Peyvandi
Type 2M/2A von Willebrand disease: A shared phenotype between type 2M and 2A. Blood advances (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Rita Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX). Blood (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Samin Mohsenian, Roberta Palla, Marzia Menegatti, Andrea Cairo, Anna Lecchi, Alessandro Casini, Marguerite Neerman-Arbez, Rosanna Asselta, Sara Scardo, Siboni Simona Maria, Jan Blatný, Ondrej Zapletal, Jean-Francois Schved, Muriel Giansily-Blaizot, Susan Halimeh, Ayman Daoud, Helen Platokouki, Helen Pergantou, Roger E G Schutgens, Monique Van Haaften-Spoor, Paul Brons, Britta A P Laros-van Gorkom, Elise Van Pinxten, Munira Borhany, Naveena Fatima, Danijela Mikovic, Marko Saracevic, Gül Nihal Özdemir, Yılmaz Ay, Michael P Makris, Caryl Lockley, Andrew D Mumford, Andrew Harvey, Steven Kenneth Austin, Amy D Shapiro, Adrianna Williamson, Catherine McGuinn, Ilene Goldberg, Philippe De Moerloose, Flora Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database. Blood advances (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Rita Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX). Blood (2024)
Shermarke Hassan, Guido A Baselli, Luca Mollica, Riccardo L Rossi, Himani Chand, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Mehran Karimi, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort. Blood advances 8 (11) (2024)
Alessandro Casini, David J Kuter, Catherine P M Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Shermarke Hassan, Guido A Baselli, Luca Mollica, Riccardo L Rossi, Himani Chand, Amal Mohamed El-Beshlawy, Mohsen Saleh Elalfy, Vijay Ramanan, Peyman Eshghi, Mehran Karimi, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET Cohort. Blood advances (2024)
Omid Seidizadeh, Andrea Cairo, Illaria Mancini, James N George, Flora Peyvandi
Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis. Blood advances 8 (16) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michiel Coppens, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Greta Mulders, Flora Peyvandi
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD). Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Omid Seidizadeh, Luca Mollica, Serena Zambarbieri, Luciano Baronciani, Andrea Cairo, Paola Colpani, Giovanna Cozzi, Maria Teresa Pagliari, Alessandro Ciavarella, Siboni Simona Maria, Flora Peyvandi
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A. Blood advances 8 (7) (2024)
Silvia Spena, Andrea Cairo, Francesca Gianniello, Emanuela Pappalardo, Mimosa Mortarino, Isabella Garagiola, Ida Martinelli, Flora Peyvandi
Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor. International journal of molecular sciences 24 (18) (2023)
Pasquale Agosti, Simona Maria Siboni, Sara Scardo, Adriana Torri, Roberta Gualtierotti, Flora Peyvandi
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A. Blood advances (2023)
Roberta Gualtierotti, Sharon E Fox, Fernanda Da Silva Lameira, Andrea Giachi, Luca Valenti, Maria Orietta Borghi, Pier Luigi Meroni, Massimo Cugno, Flora Peyvandi, null On Behalf Of The Capcovid Study Group
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients. Journal of clinical medicine 12 (11) (2023)
Barbara A Konkle, Flora Peyvandi, Donna Coffin, Mayss Naccache, Toong Youttananukorn, Glenn F Pierce, null null
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard. Haemophilia : the official journal of the World Federation of Hemophilia 30 (1) (2023)
Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth Castro Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S Key, Michael Laffan, Amy L Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Joshua Henshaw, Tara M Robinson, Wing Yen Wong, Steven W Pipe, null null
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A. The New England journal of medicine 388 (8) (2023)
Lynn Malec, An Van Damme, Anthony K C Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel D Carcao, Flora Peyvandi
Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study. Blood (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Vincenzo la Mura, Niccolò Bitto, Cecilia Capelli, Camilla Caputo, Simona Maria Siboni, Sara Arcudi, Alessandro Ciavarella, Roberta Gualtierotti, Anna Ludovica Fracanzani, Angelo Sangiovanni, Flora Peyvandi
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy. Blood advances (2023)
Lynn Daniel Malec, An Van Damme, Anthony K C Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel D Carcao, Flora Peyvandi
Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study. Blood (2023)
Armando Tripodi, Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients. Biomedicines 11 (6) (2023)
Ilaria Cutica, Mimosa Mortarino, Isabella Garagiola, Gabriella Pravettoni, Flora Peyvandi
Psychological and cognitive factors involved in decision-making process of haemophilia carriers in reproductive choices. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth Castro Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S Key, Michael Laffan, Amy L Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Joshua Henshaw, Tara M Robinson, Wing Yen Wong, Steven W Pipe, null null
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A. The New England journal of medicine 388 (8) (2023)
Ana Boban, Fariba Baghaei, Fijnvandraat Karin, Robert Klamroth, Wolfgang Miesbach, David Stephensen, Mary Kavanagh, Declan Noone, Miguel Crato, Flora Peyvandi, null null
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Barbara A Konkle, Flora Peyvandi, Donna Coffin, Mayss Naccache, Toong Youttananukorn, Glenn F Pierce, null null
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Barbara A Konkle, Flora Peyvandi, Donna Coffin, Mayss Naccache, Toong Youttananukorn, Glenn F Pierce, null null
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard. Haemophilia : the official journal of the World Federation of Hemophilia 30 (1) (2023)
Giancarlo Castaman, Flora Peyvandi, Raimondo De Cristofaro, Berardino Pollio, Matteo Nicola Dario Di Minno
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs. Journal of clinical medicine 12 (4) (2023)
Samin Mohsenian, Omid Seidizadeh, Roberta Palla, Mohammad Jazebi, Azita Azarkeivan, Somayeh Moazezi, Mohammad Reza Baghaipour, Marzia Menegatti, Flora Peyvandi
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Giancarlo Castaman, Flora Peyvandi, Raimondo De Cristofaro, Berardino Pollio, Matteo Nicola Dario Di Minno
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs. Journal of clinical medicine 12 (4) (2023)
Armando Tripodi, Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients. Biomedicines 11 (6) (2023)
Chiara Suffritti, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Cristina Novembrino, Anna Lecchi, Silvia La Marca, Lidia Padovan, Erica Scalambrino, Marigrazia Clerici, Patrizia Bono, Ferruccio Ceriotti, Antonio Muscatello, Siboni Simona Maria, Flora Peyvandi
Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study. Journal of clinical medicine 12 (17) (2023)
Omid Seidizadeh, Andrea Cairo, Luciano Baronciani, Luca Vittorio Valenti, Flora Peyvandi
Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases. NPJ genomic medicine 8 (1) (2023)
Piet Meijer, Flora Peyvandi, Guy Aaron Young, Rajiv K Pruthi, Silmara Aparecida de Lima Montalvão, Steve Kitchen
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors. International journal of laboratory hematology (2023)
Lynn Daniel Malec, An Van Damme, Anthony K C Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel D Carcao, Flora Peyvandi
Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study. Blood (2023)
Massimo Cugno, Ilaria Mancini, Dario Consonni, Valentina De Zan, Gianluigi Ardissino, Samantha Griffini, Elena Grovetti, Luigi Porcaro, Barbara Ferrari, Andrea Artoni, Flora Peyvandi
Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpura. Blood (2023)
Jeffrey I Weitz, Flora Peyvandi
ISTH Biennial Impact Report: Looking back and looking forward. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y Doral, Stacy E Croteau, Thierry Lambert, Christine L Kempton, Steven W Pipe, Richard H Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Aaron Young, Victor Jimenez Yuste
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies. Blood advances (2022)
Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi, Armando Tripodi
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection in plasma containing argatroban. International journal of laboratory hematology 44 (5) (2022)
Victor Jimenez Yuste, Flora Peyvandi, Robert Klamroth, Giancarlo Castaman, Chandrakala Shanmukhaiah, Savita Rangarajan, Jaime García Chavez, Raul Martinez, Gili Kenet, Hazaa Alzahrani, Susan Robson, Christophe Schmitt, Anna Kiialainen, Oliver Meier, Margareth Ozelo
Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY). Research and practice in thrombosis and haemostasis 6 (8) (2022)
Giancarlo Castaman, Giovanni Di Minno, Raimondo De Cristofaro, Flora Peyvandi
The Arrival of Gene Therapy for Patients with Hemophilia A. International journal of molecular sciences 23 (18) (2022)
Wolfgang A Miesbach, Fariba Baghaei, Ana Boban, Pratima Chowdary, Michiel Coppens, Daniel P Hart, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Declan Noone, Flora Peyvandi
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC. Haemophilia : the official journal of the World Federation of Hemophilia 28 (3) (2022)
Armando Tripodi, Rosa Lombardi, Massimo Primignani, Vincenzo la Mura, Flora Peyvandi, Anna L Fracanzani
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. Biomedicines 10 (2) (2022)
G Assante, A Tourna, R Carpani, F Ferrari, D Prati, Flora Peyvandi, Francesco Blasi, A Bandera, Adrien Le Guennec, Shilpa Chokshi, Vishal C Patel, I Jane Cox, L Valenti, N A Youngson
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death. Scientific reports 12 (1) (2022)
Flora Peyvandi, Kaan Kavakli, Amal El-Beshlawy, Savita Rangarajan
Management of haemophilia A with inhibitors: A regional cross-talk. Haemophilia : the official journal of the World Federation of Hemophilia 28 (6) (2022)
Ezio Zanon, Samantha Pasca, Francesco Demartis, Annarita Tagliaferri, Cristina Santoro, Isabella Cantori, Angelo Claudio Molinari, Chiara Biasoli, Antonio Coppola, Matteo Luciani, Gianluca Sottilotta, Irene Ricca, Berardino Pollio, Alessandra Borchiellini, Alberto Tosetto, Flora Peyvandi, Anna Chiara Frigo, Paolo Simioni
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry. Journal of clinical medicine 11 (7) (2022)
Michael U Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Víctor Jiménez-Yuste, Midori Shima, Peter Trask, Christine L Kempton, Craig M Kessler, Gallia G Levy, Flora Peyvandi
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3. Research and practice in thrombosis and haemostasis 6 (6) (2022)
Roberta Gualtierotti, Francesco Tafuri, Raffaella Rossio, Matteo Rota, Paolo Bucciarelli, Barbara Ferrari, Andrea Giachi, Chiara Suffritti, Massimo Cugno, Flora Peyvandi, null On Behalf Of The Principlus Study Group
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit. Journal of clinical medicine 11 (18) (2022)
Christian Bichard, Illaria Mancini, Pasquale Agosti, Marco Capecchi, Pasqualina De Leo, Sara Arcudi, Barbara Ferrari, Silvia Maria Trisolini, Francesco Longu, Claudio Fozza, Andrea Artoni, Flora Peyvandi
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura. Blood advances 6 (18) (2022)
Marie Anne Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul N Knöbl, Flora Peyvandi, Spero R Cataland, Paul Coppo, Johanna A Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Filip Callewaert, Sriya Gunawardena, Julie Lin
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, Simona Maria Siboni, Pier Mannuccio Mannucci, Flora Peyvandi
Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination. Blood advances (2022)
Maria Teresa Pagliari, Frits R Rosendaal, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Luciano Baronciani, Olga Benítez Hidalgo, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W G Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Renato Marino, Johannes Oldenburg, Ian Peake, Cristina Santoro, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Hamideh Yadegari, Eva M K Zetterberg, Flora Peyvandi, Augusto B Federici, Jeroen C J Eikenboom
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
I Mancini, P Agosti, M Boscarino, B Ferrari, A Artoni, R Palla, M Spreafico, G Crovetti, E Volpato, S Rossini, C Novelli, S Gattillo, L Barcella, M Salmoiraghi, A Falanga, Flora Peyvandi, null null
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy. Orphanet journal of rare diseases 17 (1) (2022)
Elena A Boccalandro, Valentina Begnozzi, Sofia Garofalo, Samantha Pasca, Flora Peyvandi
The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Roberta Gualtierotti, Samantha Pasca, Alessandro Ciavarella, Sara Arcudi, Andrea Giachi, Isabella Garagiola, Chiara Suffritti, Simona Maria Siboni, Flora Peyvandi
Updates on Novel Non-Replacement Drugs for Hemophilia. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Sara Arcudi, Roberta Gualtierotti, Sonia Marino, Gabriella Nicolò, Eugenia Biguzzi, Alessandro Ciavarella, Marco Boscarino, Simona Maria Siboni, Lucia Schiavone, Cristina Novembrino, Carla Valsecchi, Flora Peyvandi
Real-world data on emicizumab prophylaxis in the Milan cohort. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)

Flora Peyvandi.css-eqlu8i{font-size:small;padding-left:4px;} (F Peyvandi)

Publication Activity (10 Years)

Top Topics

Top Venues

Flora Peyvandi (F Peyvandi)